Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 2,200 | 3,134 | 2,704 | -130 | 1,346 |
| Cost of Goods | 3,502 | 2,711 | 1,793 | 973 | 1,077 |
| Gross Profit | -1,302 | 423 | 911 | -1,103 | 269 |
| Operating Expenses | 12,713 | 10,895 | 11,414 | 11,770 | 9,024 |
| Operating Income | -13,513 | -9,761 | -9,710 | -11,900 | -8,678 |
| Interest Expense | 769 | 863 | 606 | 667 | 1,119 |
| Other Income | -118 | -87 | 1 | -177 | 3,687 |
| Pre-tax Income | -14,400 | -10,711 | -10,315 | -12,744 | -6,110 |
| Net Income Continuous | -14,400 | -10,711 | -10,315 | -12,744 | -6,110 |
| Net Income | $-14,400 | $-10,711 | $-10,315 | $-12,744 | $-6,110 |
| EPS Basic Total Ops | -0.59 | -0.52 | -0.53 | 7.57 | -0.47 |
| EPS Basic Continuous Ops | -0.59 | -0.52 | -0.53 | 6.66 | -0.47 |
| EPS Diluted Total Ops | -0.59 | -0.52 | -0.53 | 7.43 | -0.53 |
| EPS Diluted Continuous Ops | -0.59 | -0.52 | -0.53 | 6.62 | -0.44 |
| EBITDA(a) | $-12,765 | $-9,167 | $-9,213 | $-11,504 | $-8,436 |